Why didn’t nonprofits and the NIH require ‘reasonable’ pricing for Zolgensma? That may happen in France
(By James Love for STAT) When a new drug emerges from research largely funded by grants from charities and government
Read More(By James Love for STAT) When a new drug emerges from research largely funded by grants from charities and government
Read MoreIn Doug Badger, senior fellow at the Galen Institute, opinion column published by The Daily Signal, writes how according to
Read More(By Jackie Drees for Becker’s Hospital Review) University Hospital patients will soon be able to use Lyft to receive free rides
Read More(By Alia Paavola for Becker’s Hospital Review) Walmart’s plan to open comprehensive and low-cost primary health clinics in Georgia is
Read MoreAs American lawmakers attempt to stem spiraling drug costs, they might find inspiration in Germany, where the government’s regulatory model
Read MoreA new study from Rice University and Blue Cross and Blue Shield of Texas found that when health systems acquired
Read More(By Kelly Gooch for Becker’s Hospital Review) Nearly 370 organizations representing patients, physicians, healthcare professionals, hospitals and other healthcare stakeholders
Read MoreThe Health Savings for Seniors Act (H.R. 3796) a bipartisan legislation would allow any senior enrolled in Medicare to contribute
Read More(By Morgan Haefner for Becker’s Hospital Review) CVS Health’s $69 billion purchase of Aetna is official after a federal judge
Read More(By Lauren Weber for Kaiser Health News) Emory University medical fellow Dr. Nicole Herbst was shocked when she saw three
Read More